The Foundation of Safe Research
Baseline bloodwork serves as your safety foundation before beginning any peptide research protocol. Without knowing your starting values, you cannot properly assess changes or potential adverse effects during your research.
Essential Baseline Markers
Key markers to establish include complete blood count (CBC), comprehensive metabolic panel (CMP), lipid panel, and hormone levels relevant to your research peptide. For growth hormone releasing peptides like GHRP-2 or CJC-1295, baseline IGF-1 levels are crucial. For metabolic peptides, glucose and insulin markers provide essential reference points.
Timing and Documentation
Obtain bloodwork 1-4 weeks before starting your protocol when possible. Document all values and establish a monitoring schedule based on your peptide's known effects profile. Some peptides may require monitoring every 4-6 weeks, while others need less frequent assessment.
Red Flags to Watch For
Baseline abnormalities in liver function, kidney markers, or blood cell counts may contraindicate certain peptides. Elevated inflammatory markers or autoimmune indicators could affect peptide selection and dosing considerations.
This information is for research purposes only and does not constitute medical advice. Always work with qualified healthcare professionals for proper laboratory interpretation and protocol design.